Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
July 14, 2026 4:01 PM EDTKIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2026.
Financial Highlights
Fiscal 4Q26 revenue of $28.6 million, an increase of 66% compared to the prior year period.FY26 revenue of $95.1 million, an increase of 59% compared to FY25.Fiscal 4Q26... More


